ID
20083
Description
An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: AVA100468, Sponsor: GSK
Keywords
Versions (2)
- 1/31/17 1/31/17 -
- 2/6/17 2/6/17 -
Uploaded on
February 6, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Study Conclusion GSK-AVA100468 NCT00381238
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Similar models
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])
No comments